Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective-Reference-Cited by-同舟云学术

Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective

Published:2017-01-04 Issue:6 Volume:24 Page:1722-1730
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Picozzi Vincent J.,Oh Stephen Y.,Edwards Alicia,Mandelson Margaret T.,Dorer Russell,Rocha Flavio G.,Alseidi Adnan,Biehl Thomas,Traverso L. William,Helton William S.,Kozarek Richard A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-016-5716-z.pdf

Reference34 articles.

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.

2. Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO- 001 randomized trial. JAMA. 2013;310:1473–81.

3. Picozzi VJ, Kozarek RA, Traverso LW. Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg. 2003;185:476–80.

4. Rocha FG, Hashimoto Y, Traverso LW, et al. Interferon-based adjuvant chemoradiation for resected pancreatic head cancer: long-term follow-up of the Virginia Mason Protocol. Ann Surg. 2016;263(2):376–84

5. Rose JB, Rocha FG, Alseidi A, et al. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival. Ann Surg Oncol. 2014; 21:1530–37.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MLH1 Inhibits Metastatic Potential of Pancreatic Ductal Adenocarcinoma via Downregulation of GPRC5C;Laboratory Investigation;2024-09

2. The relationship and clinical significance of lactylation modification in digestive system tumors;Cancer Cell International;2024-07-15

3. Dramatic improvements in outcome following pancreatoduodenectomy for pancreatic and periampullary cancers;British Journal of Cancer;2024-06-27

4. Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis;Annals of Surgical Oncology;2024-05-06

5. Undifferentiated sarcomatoid carcinoma of the pancreas-a single-institution experience with 23 cases;BMC Cancer;2024-02-22